This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Sirtris Pharmaceuticals: Living Healthier, Longer (Abridged)
Stuart, Toby; Webber, JamesCase HBS-813029-EEntrepreneurshipDescribes a set of key strategic decisions facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate?Starting at €8.20
-
Tennant Company
Stuart, Toby; Applegate, Lynda M.; Weber, JamesCase HBS-810040-EEntrepreneurshipTennant, a leading producer of floor cleaning equipment, must determine how to create, finance, structure, staff, govern, measure and manage a new venture for developing a fundamentally new product line. In 2005, Tennant Company had developed an innovative, environmentally friendly, cleaning technology that could potentially revolutionize cleaning. Historically, Tennant was a producer of floor and carpet washing machines for industrial and commer...Starting at €8.20
-
KiOR: Catalyzing Clean Energy
Nanda, Ramana; Stuart, TobyCase HBS-809092-EEntrepreneurshipBiofuels start-up KiOR was developing a proprietary technology that had the potential to dramatically impact the emerging renewable energy landscape: a process that converted cellulosic biomass into "bio-crude," a hydrocarbon mixture with properties to those of crude oil. KiOR had been operating as a virtual organization, but with venture financing in place, founder and chief technology officer Paul O'Connor and the KiOR board needed to decide wh...Starting at €8.20
-
GSK's Acquisition of Sirtris: Independence or Integration, Teaching Note
Stuart, TobyTeaching Note HBS-811012-EEntrepreneurshipTeaching Note for 809026.Starting at €0.00
-
Sirtris Pharmaceuticals: Living Healthier, Longer
Stuart, Toby; Kiron, DavidCase HBS-808112-EEntrepreneurshipDescribes a set of key strategic decisions facing the scientific founder and CEO of a promising, Early stage bio-pharmaceuticals company.l Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate?Starting at €8.20
-
Manchester Bidwell Corporation: The Replication Question
Stuart, Toby; Hardymon, G. Felda; Heskett, James L.; Leamon, AnnCase HBS-810097-EEntrepreneurshipBill Strickland, CEO of Manchester Bidwell Corporation, must decide the best way to replicate his innovative, award-winning approach to curing poverty. Manchester Bidwell's approach, which provides both adult job-training tuned to fill the needs of local industries and after-school art instruction for at-risk youth, has proven highly effective over the 40 years Strickland has operated it. He wants to replicate this strategy across 100 or 200 citi...Starting at €8.20
-
Yieldex (B)
Stuart, Toby; Wagonfeld, Alison BerkleyCase HBS-809091-EEntrepreneurshipYieldex CEO Tom Shields was hired by the company's technical founder, Doug Cosman, in October 2007. One of Shields' top priorities is finding a vice president of engineering to manage the company's software development efforts. Shields and Costman disagree about the ideal profile of the new hire. Shields found a candidate that he likes, and he wonders about the implications of hiring the person against Cosman's wishes.Starting at €5.74
-
Yieldex (A)
Stuart, Toby; Wagonfeld, Alison BerkleyCase HBS-809090-EEntrepreneurshipYieldex Founder, Doug Cosman, is faced with the decision to sell his young software start-up for $4 million or to hire a CEO (Tom Shields) and pursue Series A venture capital financing. His angel investors and CEO candidate Tom Shields believe he should reject the offer and focus on building the company into a bigger enterprise. Cosman is attracted to the financial rewards offered by the potential acquirer.Starting at €8.20
-
Sirtis Pharmaceuticals: Living Healthier, Longer, Teaching Note
Stuart, TobyTeaching Note HBS-809050-EEntrepreneurshipTeaching Note for [808-112].Starting at €0.00
-
OvaScience
Hardymon, G. Felda; Nicholas, Tom; Stuart, Toby; Fisher, NoahCase HBS-815058-EEntrepreneurshipIn early April 2012, Michelle Dipp, MD, Ph.D, CEO and co-founder of OvaScience, had just received a buyout offer from PG Ventures, a private equity firm interested in acquiring the innovative fertility treatments company. The company's first promising fertility treatment, AUGMENT (Autologous Germ-line Mitochondrial Energy Transfer), had the potential to improve egg quality, increase the success of IVF cycles, and decrease the incidence of multipl...Starting at €8.20